如何才能三款小核酸药物进入十亿美元行列

> 数据图表

如何才能三款小核酸药物进入十亿美元行列

2026-3-4

三款小核酸药物进入十亿美元行列表：全球已上市小核酸药物商业化表现商品名成分词AmvuttraVutrisiranSpinraza 诺西那生Leqvio 英克司兰钠Exondys 51 依特立生GivlaariGivosiranAmondys45WainuaCasimersen依普隆特生钠OxlumoLumasiranOnpattro 帕替司兰Vyondys 53 GolodirsenTRYNGOLZAOlezarsenQalsody托夫生WaylivraVolanesorsen企业AlnylamPharmaceuticals渤健制药诺华制药SareptaTherapeuticsAlnylamPharmaceuticalsSareptaTherapeutics阿斯利康制药AlnylamPharmaceuticalsAlnylamPharmaceuticalsSareptaTherapeuticsIonisPharmaceuticals渤健制药苏庇医药Qfitlia芬妥司兰钠赛诺菲制药DAWNZERADonidalorseIonisnPharmaceuticalsTegsedi伊诺特生苏庇医药IzervayAvacincaptad pegolTegsedi伊诺特生安斯泰来制药IonisPharmaceuticalsTegsediAndWaylivraVolanesorseIonisnPharmaceuticals资料来源：Insight，国盛证券研究所2020 年2021 年--$2052.10M-$1905.10M$12.00M2022 年$93.80M$1793.50M$112.00M2023 年2024 年2025 年2025 年yoy$558.00M$970.45M$2313.84M138%$1741.20M$355.00M$1573.20M$754.00M$1546.80M$1198.00M$422.01M$454.36M$511.75M$541.00M$528.30M$538.38M$55.11M$127.82M$173.14M$219.00M$255.87M$308.49M--$68.53M$214.58M$274.00M$301.41M$299.10M---$85.00M$212.00M$0.33M$59.59M$69.78M$110.00M$167.05M$191.44M$306.08M$474.74M$557.61M$355.00M$252.86M$172.79M$33.86M$89.51M$117.44M$130.00M$137.47M$128.08M-2%59%2%21%-1%149%15%-32%-7%168%12%------------$14.04M$15.00M-----$5.90M$20.35M---$108.00M$32.40M$26.21M--$86.90M$29.32M$10.18M$8.00M$49.53M$42.34M$29.28M$17.28M----$82.72M$400.99M--$70.00M$55.50M$30.00M$35.00M$34.19M----靶点TTRSMN2PCSK9DMDALAS1DMDTTRHAO1TTRDMDAPOC3SOD1APOC3AT-IIIKLKB1TTRC5TTRAPOC3成分类别siRNAASOsiRNAASOsiRNAASOASOsiRNAsiRNAASOASOASOASOsiRNAASOASO适配体ASOASO

国盛证券健康医疗